ClinicalIntelPulse

Endpoints (16 live)

• GET /api/clinical/trial-check — ClinicalTrials.gov lookup, deterministic. Answers "what is the status of NCT02142738", "recruiting phase-3 melanoma trials", "Pfizer trial pipeline". Single trial by NCT id (status, phase, sponsor, enrollment, dates, countries) or search by condition/sponsor with phase and status filters. Typed records straight off the official v2 API — no LLM, no key, public domain. (0.02 USDC on Base)
• GET /api/clinical/recall-check — Checks clinical recall status for a record or patient lookup. (0.1 USDC on Base)
• GET /api/clinical/drug-check — What is this medication? Plain-language explainer for any prescription or OTC drug from its FDA-approved label — what it treats, how to take it, boxed warnings, who should not take it, common and serious side effects, pregnancy notes. For patient, caregiver, pharmacy, and health-assistant agents. (0.1 USDC on Solana)
• GET /api/clinical/approval-outlook — FDA/EMA drug approval probability + PDUFA calendar for a disease area — which Phase 3 drugs are most likely to win approval in 12-24 months, with mechanism, trial results, approval-probability scores and historical phase-3 success rates. Worldwide. For biotech-investing and payer agents. (0.25 USDC on Base)
• GET /api/clinical/failure-analysis — Clinical trial failure analysis for a disease area — why Phase 2/3 trials failed (wrong target, patient population, endpoint, dose, safety), failure taxonomy with percentages, phase-transition success rates and design lessons. Worldwide. For drug developers and biotech investors. (0.2 USDC on Base)
• GET /api/clinical/mechanism-map — Drug mechanism-of-action + molecular target landscape for any disease — targets in active trials, approved agents by MOA, crowded vs novel mechanisms and first-in-class openings, with key publications. Worldwide. For drug-discovery and VC agents. (0.2 USDC on Base)
• GET /api/clinical/sponsor-intel — Pharma/biotech company pipeline intelligence — full drug pipeline by phase, therapeutic-area coverage, FDA approval history, partnerships, competitive positioning and investment catalysts for any sponsor. Worldwide. For investor and M&A agents. (0.2 USDC on Solana)
• GET /api/clinical/global-trials — Global clinical trial landscape for any disease — geographic distribution by country across WHO ICTRP registries (US, EU, China, India, Japan, Brazil, Africa and more), regulatory pathways, access gaps and unmet need by region. For CRO, global-pharma and advocacy agents. (0.15 USDC on Base)
• GET /api/clinical/deal-signal — Biotech M&A + licensing deal signal for clinical-stage drugs — Phase 2/3 assets most likely to be acquired or licensed, with acquisition targets, deal comps, transaction multiples and estimated deal values. Worldwide. For biotech-investing and BD agents. (0.35 USDC on Base)
• GET /api/clinical/patient-finder — Recruiting clinical trial finder for a disease or diagnosis — actively recruiting trials with plain-language summaries, eligibility (who can/cannot join), country filter, contacts and how to apply, across 400,000+ ClinicalTrials.gov studies worldwide. For patient-advocacy and provider agents. (0.1 USDC on Base)
• GET /api/clinical/deal-signal-lite — Deterministic preview of biotech M&A deal-signal candidates — Phase 2/3 trial counts and the industry-sponsored asset list straight off ClinicalTrials.gov, no LLM synthesis. For agents with small per-call budgets; upgrade to deal-signal for acquisition rationale, deal comps with dollar values, likely acquirers and timing signals. (0.25 USDC on Solana)
• GET /api/clinical/disease-landscape — Competitive drug pipeline landscape for any disease — full Phase 2/3 trial map, mechanism-of-action coverage, approved drugs, PDUFA calendar, M&A activity, opportunity gaps and investment thesis. Worldwide. For biotech and pharma intelligence agents. (0.35 USDC on Base)
• GET /api/clinical/pipeline-scan — Clinical trial pipeline scan for any disease — all active Phase 2/3 trials with trial counts, sponsor landscape, geographic distribution, mechanism breakdown and pipeline density, across 400,000+ trials worldwide. For biotech-investing and pharma agents. (0.15 USDC on Base)
• GET /api/clinical/disease-landscape-lite — Deterministic preview of the disease pipeline landscape — Phase 2/3 trial counts, sponsor rollup, trial-status breakdown and a sample of trials straight off ClinicalTrials.gov. No LLM synthesis. For agents with small per-call budgets; upgrade to disease-landscape for approved drugs, mechanism gaps, PDUFA calendar, deal activity and an opportunity score. (0.25 USDC on Base)
• GET /api/clinical/trial-brief — Clinical trial deep dive by NCT ID — full trial design, primary/secondary endpoints, enrollment status and countries, sponsor, recruitment criteria, outcomes and publications for any ClinicalTrials.gov study. For research and biotech agents. (0.1 USDC on Base)
• GET /api/clinical/interaction-check — Can these medications be taken together? Cross-references the FDA-approved drug-interaction and contraindication sections for 2+ drugs and flags possible interactions in plain language, with severity and what-to-do. For patient, caregiver, pharmacy, and health-assistant agents managing a medication list. (0.15 USDC on Solana)